General Information of Drug (ID: DMW0XQM)

Drug Name
GSK3537142
Indication
Disease Entry ICD 11 Status REF
Aggressive cancer 2A00-2F9Z Phase 1 [1]
Cross-matching ID
TTD ID
DVRS03

References

1 Clinical pipeline report, company report or official report of GlaxoSmithKline